Scarica l'app Stockscreener
20.43
2.30%
-0.48
Pre-mercato:
20.43
Precedente Chiudi:
$20.91
Aprire:
$20.58
Volume 24 ore:
1.36M
Relative Volume:
0.55
Capitalizzazione di mercato:
$2.61B
Reddito:
$642.82M
Utile/perdita netta:
$-43.54M
Rapporto P/E:
-58.44
EPS:
-0.3496
Flusso di cassa netto:
$130.12M
1 W Prestazione:
+11.15%
1M Prestazione:
-7.68%
6M Prestazione:
+74.32%
1 anno Prestazione:
+113.26%
Intervallo 1D:
$20.33
$21.20
Intervallo di 1 settimana:
$18.09
$21.20
Portata 52W:
$6.78
$23.56
10 X Genomics Inc Stock (TXG) Company Profile
Nome
10 X Genomics Inc
Settore
Industria
Telefono
(925) 401-7300
Indirizzo
6230 STONERIDGE MALL ROAD, PLEASANTON, CA
Compare TXG vs VEEV, BTSG, TEM, HQY, WAY
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TXG
10 X Genomics Inc
|
20.43 | 2.61B | 642.82M | -43.54M | 130.12M | -0.3496 |
VEEV
Veeva Systems Inc
|
178.28 | 29.12B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
42.83 | 8.23B | 12.91B | 104.80M | 394.69M | 0.8769 |
TEM
Tempus Ai Inc
|
45.53 | 8.14B | 1.27B | -245.03M | -245.36M | -1.4071 |
HQY
Healthequity Inc
|
83.85 | 7.08B | 1.31B | 215.20M | 408.32M | 2.4627 |
WAY
Waystar Holding Corp
|
24.85 | 4.76B | 1.10B | 112.09M | 283.19M | 0.6096 |
10 X Genomics Inc Stock (TXG) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-11 | Downgrade | Citigroup | Buy → Neutral |
| 2025-12-02 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-09-11 | Iniziato | Piper Sandler | Neutral |
| 2025-02-13 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-09-03 | Iniziato | Leerink Partners | Outperform |
| 2024-07-22 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-07-18 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-07-10 | Downgrade | Deutsche Bank | Buy → Hold |
| 2024-06-27 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2024-06-25 | Downgrade | Guggenheim | Buy → Neutral |
| 2024-06-03 | Ripresa | Jefferies | Hold |
| 2024-05-01 | Downgrade | TD Cowen | Buy → Hold |
| 2023-12-14 | Iniziato | Guggenheim | Buy |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-12-12 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2023-07-05 | Ripresa | JP Morgan | Overweight |
| 2023-05-10 | Iniziato | Barclays | Overweight |
| 2023-03-31 | Iniziato | Stephens | Overweight |
| 2023-02-02 | Iniziato | UBS | Neutral |
| 2022-12-14 | Iniziato | Deutsche Bank | Buy |
| 2022-08-18 | Downgrade | Goldman | Neutral → Sell |
| 2022-07-25 | Iniziato | Canaccord Genuity | Buy |
| 2022-07-15 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-07-15 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-09-14 | Downgrade | BofA Securities | Buy → Neutral |
| 2021-03-15 | Iniziato | William Blair | Outperform |
| 2020-12-02 | Iniziato | Goldman | Neutral |
| 2020-09-09 | Iniziato | Morgan Stanley | Overweight |
| 2020-07-10 | Iniziato | Stifel | Buy |
| 2020-03-05 | Iniziato | Guggenheim | Buy |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-10-07 | Iniziato | BofA/Merrill | Buy |
| 2019-10-07 | Iniziato | Cowen | Outperform |
| 2019-10-07 | Iniziato | JP Morgan | Overweight |
| 2019-09-24 | Iniziato | Evercore ISI | Outperform |
Mostra tutto
10 X Genomics Inc Borsa (TXG) Ultime notizie
10x Genomics Inc (TXG) Trading 4.54% Higher on Mar 25 - GuruFocus
10x Genomics (NASDAQ:TXG) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
10x Genomics (NASDAQ:TXG) CEO Serge Saxonov Sells 10,000 Shares - MarketBeat
Serge Saxonov Sells 5,000 Shares of 10x Genomics (NASDAQ:TXG) Stock - MarketBeat
10x genomics CEO Saxonov sells $288,908 in stock - Investing.com
10x Genomics (NASDAQ: TXG) CEO sells 15,000 shares under Rule 10b5-1 plan - Stock Titan
Vanguard realigns reporting; subsidiaries to report TXG holdings (TXG) - Stock Titan
Bioptimus launches spatial biology atlas with 10x Genomics - Investing.com
Bioptimus Announces STELA: The World's Largest Clinically Linked Spatial Biology Atlas, alongside key partners 10x Genomics and Broad Clinical Labs - The AI Journal
A new atlas aims to map 100,000 patient samples across 3 continents - Stock Titan
Bioptimus launches spatial biology atlas with 10x Genomics By Investing.com - Investing.com Australia
Vanguard amends 13G for 10X Genomics (NASDAQ: TXG) reporting 0 shares - Stock Titan
10x Genomics Undervalued Amid Consumables-Led Transition - National Today
10x Genomics: Undervalued Amid Consumables-Led Transition (NASDAQ:TXG) - Seeking Alpha
Cathie Wood’s ARK sells Bullish stock, buys more 10X Genomics By Investing.com - Investing.com India
Cathie Wood’s ARK sells Bullish stock, buys more 10X Genomics - Investing.com
These Are the Only 3 Stocks That Cathie Wood Bought Last Week - The Motley Fool
TXG Stock Price, Quote & Chart | 10X GENOMICS INC-CLASS A (NASDAQ:TXG) - ChartMill
10x Genomics Stock Analysis: Recent Gains vs. Long-Term Growth Challenges | 2026News and Statistics - IndexBox
10X Genomics Hits Day High with 8.39% Surge Amid Market Volatility - Markets Mojo
ARK Investment Increases Stake in 10x Genomics (TXG) with Major Purchase - GuruFocus
Cathie Wood’s ARK adds 10x Genomics stock, trims Arcturus - Investing.com
10X Genomics Stock Hits Day Low of $15.90 Amid Price Pressure - Markets Mojo
10x Genomics Inc Class A Trade Ideas — LSX:A2PPQJ - TradingView
10x Genomics Inc (TXG) Trading Down 10.96% on Mar 16 - GuruFocus
10x Genomics Shares Drop 10.9% Amid Market Volatility - National Today
10x Genomics Down Nearly 12%, on Pace for Largest Percent Decrease Since February 2025 -- Data Talk - Moomoo
10x Genomics (NASDAQ:TXG) Shares Down 10.9%Here's Why - MarketBeat
10x Genomics (TXG) Shares Drop Nearly 14% - GuruFocus
TXG SEC Filings10X Genomics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Cathie Wood’s ARK trims 10X Genomics stock, adds DraftKings - Investing.com Nigeria
Cathie Wood’s ARK stock trades highlight CRISPR buys, 10x Genomics sells - Investing.com
Cathie Wood’s ARK stock trades highlight CRISPR buys, 10x Genomics sells By Investing.com - Investing.com South Africa
10X Genomics Experiences Evaluation Revision Amid Mixed Market Signals and Performance Metrics - Markets Mojo
10X Genomics Stock Hits Day Low of $18.80 Amid Price Pressure - Markets Mojo
Level Four Advisory Services LLC Acquires New Position in 10x Genomics $TXG - MarketBeat
Smart Money: Can 10x Genomics Inc grow without dilutionWeekly Trend Summary & Breakout Confirmation Alerts - baoquankhu1.vn
Risk Report: Can 10x Genomics Inc grow without dilutionJuly 2025 Sentiment & High Return Trade Guides - baoquankhu1.vn
10x Genomics $TXG Shares Bought by JPMorgan Chase & Co. - MarketBeat
Citigroup Inc. Increases Holdings in 10x Genomics $TXG - MarketBeat
ARK Investment Cuts Stake in 10x Genomics - National Today
10x genomics CEO Saxonov sells $367,096 in shares - Investing.com UK
10x Genomics $TXG Shares Sold by ARK Investment Management LLC - MarketBeat
Amova Asset Management Americas Inc. Has $62.86 Million Stock Holdings in 10x Genomics $TXG - MarketBeat
Life Sciences Tools & Services Stocks Q4 In Review: 10x Genomics (NASDAQ:TXG) Vs Peers - Finviz
10x Genomics (TXG) CEO sells shares and makes stock gift - Stock Titan
TXG Technical Analysis & Stock Price Forecast - Intellectia AI
10x Genomics $TXG Position Lifted by Vanguard Group Inc. - MarketBeat
10X Genomics Experiences Revision in Stock Evaluation Amid Strong Market Performance - Markets Mojo
Breaking Down 10x Genomics: 11 Analysts Share Their Views - Sahm
Commit To Buy 10x Genomics At $15, Earn 20.6% Annualized Using Options - Nasdaq
10 X Genomics Inc Azioni (TXG) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.75%
0.54%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):